The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia

The impact of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) on subsequent allogeneic transplantation is uncertain. To better understand this relationship, we retrospectively compared 145 patients with CML receiving IM for a minimum of 3 months before allogeneic hematopoietic ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Oehler, Vivian G., Gooley, Ted, Snyder, David S., Johnston, Laura, Lin, Allen, Cummings, Carrie C., Chu, Su, Bhatia, Ravi, Forman, Stephen J., Negrin, Robert S., Appelbaum, Frederick R., Radich, Jerald P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2007
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1794075/
https://ncbi.nlm.nih.gov/pubmed/17062727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-06-031682
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados